Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Neoplasm Metastasis × anlotinib × 1 year × Clear all

Sponsor

Conditions

Small Cell Lung Carcinoma 6 Carcinoma, Non-Small-Cell Lung 5 Thyroid Neoplasms 3 Sarcoma 3 Pancreatic Neoplasms 2 Gallbladder Neoplasms 2 Esophageal Squamous Cell Carcinoma 2 Cholangiocarcinoma 2 Breast Neoplasms 2 Whole-Brain Radiotherapy 1 Triple Negative Breast Neoplasms 1 Stomach Neoplasms 1 Small Cell Lung Cancer Extensive Stage 1 Sarcoma, Synovial 1 Sarcoma, Alveolar Soft Part 1 Proteinuria 1 Progression Free Survival(PFS) 1 Platinum-resistant Ovarian Cancer (PROC) 1 Lung Neoplasms 1 Limited Stage Small Cell Lung Cancer 1 Leiomyosarcoma 1 HER2-Negative Breast Cancer 1 Extensive Stage Lung Small Cell Cancer 1 Craniopharyngioma 1 Colonic Neoplasms 1 Carcinoma, Renal Cell 1 Biliary Tract Neoplasms 1 Bile Duct Neoplasms 1 Advanced Thyroid Cancer Patients Who Received Target Therapy 1

Interventions

pembrolizumab 87 Specimen Handling 51 Nivolumab 44 Magnetic Resonance Spectroscopy 44 Biopsy 43 Radiosurgery 29 Paclitaxel 26 Gemcitabine 26 Ipilimumab 22 Carboplatin 21 trastuzumab deruxtecan 20 Irinotecan 20 Cisplatin 20 Capecitabine 19 Leucovorin 18 Fluorouracil 17 Cyclophosphamide 17 Fulvestrant 16 Docetaxel 16 Drug Therapy 15 atezolizumab 14 Pemetrexed 14 Oxaliplatin 14 Cetuximab 14 Bevacizumab 14 abemaciclib 13 130-nm albumin-bound paclitaxel 13 Taxes 12 Radiotherapy 12 palbociclib 11

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡